Skip to main content

Advertisement

ADVERTISEMENT

Mapping/Ablation

Feature Interview
12/19/2013
In this interview, EP Lab Digest speaks with William H. Spear, MD, FACC, FHRS from Advocate Christ Medical Center (ACMC) in Oak Lawn, Illinois about his use of the recently acquired Stereotaxis technology Vdrive™ with V-Sono™. 
In this interview, EP Lab Digest speaks with William H. Spear, MD, FACC, FHRS from Advocate Christ Medical Center (ACMC) in Oak Lawn, Illinois about his use of the recently acquired Stereotaxis technology Vdrive™ with V-Sono™. 
In this interview, EP Lab Digest...
12/19/2013
EP Lab Digest
Letter from the Editor
12/19/2013
A limitation of implantable defibrillators is T-wave oversensing (TWO). Modern ICDs use filtering techniques to avoid sensing the T-wave. However, the T-wave can be large relative to the QRS in some patients and lead to double-counting by the...
A limitation of implantable defibrillators is T-wave oversensing (TWO). Modern ICDs use filtering techniques to avoid sensing the T-wave. However, the T-wave can be large relative to the QRS in some patients and lead to double-counting by the...
A limitation of implantable...
12/19/2013
EP Lab Digest
Feature Story
11/25/2013
All co-authors were the first registered cardiovascular specialist assistants (RCSAs) whose credentials were “grandfathered” in 2010 to undergo training to become certified cardiovascular medical simulation trainers (CTAEs).
All co-authors were the first registered cardiovascular specialist assistants (RCSAs) whose credentials were “grandfathered” in 2010 to undergo training to become certified cardiovascular medical simulation trainers (CTAEs).
All co-authors were the first...
11/25/2013
EP Lab Digest
Feature Story
11/25/2013
The Parkview Heart Institute recently became the first in Indiana to implant Boston Scientific’s S-ICD System for the prevention of life-threatening ventricular arrhythmias.
The Parkview Heart Institute recently became the first in Indiana to implant Boston Scientific’s S-ICD System for the prevention of life-threatening ventricular arrhythmias.
The Parkview Heart Institute...
11/25/2013
EP Lab Digest
Feature Interview
11/25/2013
In this interview, EPLD speaks with Naser Partovi, Founder and CEO of Sanitas Inc., a privately held San Diego company that develops web and mobile software to help people manage their health.
In this interview, EPLD speaks with Naser Partovi, Founder and CEO of Sanitas Inc., a privately held San Diego company that develops web and mobile software to help people manage their health.
In this interview, EPLD speaks...
11/25/2013
EP Lab Digest
Feature Interview
11/25/2013
In this interview, EP Lab Digest speaks with Nancy Lurker, CEO of PDI, Inc. about CardioPredict™, a molecular diagnostic test developed by Transgenomic, Inc.
In this interview, EP Lab Digest speaks with Nancy Lurker, CEO of PDI, Inc. about CardioPredict™, a molecular diagnostic test developed by Transgenomic, Inc.
In this interview, EP Lab Digest...
11/25/2013
EP Lab Digest
Feature Interview
11/25/2013
In this article, Dr. Christian Ruff discusses the North American Thrombosis Forum’s Atrial Fibrillation Action Initiative, created to identify multidisciplinary best practices for stroke prevention in atrial fibrillation.
In this article, Dr. Christian Ruff discusses the North American Thrombosis Forum’s Atrial Fibrillation Action Initiative, created to identify multidisciplinary best practices for stroke prevention in atrial fibrillation.
In this article, Dr. Christian...
11/25/2013
EP Lab Digest
Letter from the Editor
11/25/2013
This is critical data that should not be ignored. Patients with AF should not ignore the relationship between operator experience and quality outcomes, and neither should those involved in hospital credentialing.
This is critical data that should not be ignored. Patients with AF should not ignore the relationship between operator experience and quality outcomes, and neither should those involved in hospital credentialing.
This is critical data that...
11/25/2013
EP Lab Digest
Letter from the Editor
10/29/2013
The evidence is mounting that not just patients with ARVC/D, but also those who are asymptomatic carriers of the mutation, should avoid participation in aerobic exercises and endurance training. 
The evidence is mounting that not just patients with ARVC/D, but also those who are asymptomatic carriers of the mutation, should avoid participation in aerobic exercises and endurance training. 
The evidence is mounting that...
10/29/2013
EP Lab Digest
Feature Story
10/29/2013
Training programs dedicated to outcomes and quality of care research help meet the growing national demand for scholars with specialized research capabilities.
Training programs dedicated to outcomes and quality of care research help meet the growing national demand for scholars with specialized research capabilities.
Training programs dedicated to...
10/29/2013
EP Lab Digest

Advertisement

Advertisement

Advertisement